Chronic intestinal pseudoobstruction (CIPO) is a serious complication in patients with connective tissue disease (CTD) and is sometimes life-threatening or fatal despite intensive medical treatment. Here, we report a patient with dermatomyositis (DM) and anti-EJ autoantibody who developed CIPO that was improved by octreotide. Because her abdominal pain and bloatedness were so severe and persistent, we introduced octreotide to relieve symptoms. In this case, continuous intravenous administration as well as long-acting subcutaneous injection of octreotide was effective for treating CIPO.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112325PMC
http://dx.doi.org/10.1155/2016/9510316DOI Listing

Publication Analysis

Top Keywords

dermatomyositis anti-ej
8
anti-ej autoantibody
8
chronic intestinal
8
intestinal pseudoobstruction
8
case dermatomyositis
4
autoantibody chronic
4
pseudoobstruction treated
4
octreotide
4
treated octreotide
4
octreotide chronic
4

Similar Publications

Article Synopsis
  • * A total of 69 patients were analyzed, showing high concordance for certain antibodies (like anti-Ku and anti-PM/Scl) and moderate agreement for others (like anti-Jo1 and anti-Mi-2), while some antibodies could only be detected by one method.
  • * The results suggest that LB may be more sensitive for detecting multiple MSAs and specific antibodies, while IP performs well for dermatomyositis-associated MSAs
View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed clinical characteristics and prognostic factors of patients with idiopathic inflammatory myopathy (IIM) who also had interstitial lung disease (ILD) and included 39 males and 111 females with a mean onset age of 50.4 years and a median disease duration of 3 months.
  • - Among the patients, 97 had dermatomyositis (DM-ILD) and 53 had antisynthetase syndrome (ASS-ILD), with DM-ILD patients showing higher rates of anti-MDA5 antibodies and common symptoms such as skin ulcers and rapidly progressing ILD, while ASS-ILD patients showed higher rates of anti-Jo-1 antibodies and pericardial effusion.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the presence of myositis-specific and myositis-associated autoantibodies (MSAs/MAAs) in a group of Indian children with juvenile dermatomyositis (JDM) and how these antibodies relate to clinical features and patient outcomes.
  • A total of 43 children were assessed, with 81.4% testing positive for at least one type of autoantibody; the most common were anti-NXP2, anti-TIF1γ, and anti-MDA-5.
  • While many patients showed positive responses to treatment, the study found no clear link between the specific autoantibody profiles and the successful achievement of complete clinical responses or remission.
View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) is a life-threatening respiratory disease characterized by severe acute infection. In some cases, COVID-19 symptoms may persist for a long term, posing a significant social problem. Long-term COVID-19 symptoms resemble those observed in various autoimmune diseases, such as dermatomyositis and polymyositis.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the high-resolution computed tomography (HRCT) findings in patients with interstitial lung disease (ILD) associated with anti-aminoacyl-tRNA synthetase (ARS) antibodies, a condition known as Antisynthetase syndrome (ASSD).
  • The analysis included 24 patients, focusing on clinical symptoms and HRCT patterns, revealing the nonspecific interstitial pneumonia (NSIP) as the most common finding, followed by usual interstitial pneumonia (UIP).
  • While the patient demographics showed a balanced male-to-female ratio and a median age of 53, no significant differences were found in HRCT patterns or types of antibodies between those with myositis (polymyositis/dermatomyositis)
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!